Well-being Holdings, Inc.
CIK:0001793906|SEC Filings
Consolidated Statement of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended |
|---|---|---|
Jun. 30, 2020 |
Jun. 30, 2020 |
|
| Operating Expense: | ||
| General and administrative expenses | $ 6,536 | $ 45,566 |
| Total operating expenses | 6,536 | 45,566 |
| Interest expenses | 848 | 1,788 |
| NET LOSS | (7,384) | (47,354) |
| Foreign currency translation adjustment | 42 | (52) |
| TOTAL COMPREHENSIVE LOSS | $ (7,342) | $ (47,406) |
| BASIC AND DILUTED NET LOSS PER COMMON SHARE | $ (0.00) | $ 0.00 |
| WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED | 20,000,000 | 20,000,000 |
Consolidated Statements of Cash Flows (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended |
|---|---|---|
Jun. 30, 2020 |
Jun. 30, 2020 |
|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $ (7,384) | $ (47,354) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Imputed Interest | 848 | 1,788 |
| Net cash used in operating activities | (45,566) | |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from due to related party | 45,627 | |
| Net cash provided by financing activities | 45,627 | |
| Net effect of exchange rate changes on cash | (52) | |
| Net change in cash and cash equivalents | 9 | |
| Cash and cash equivalents - beginning of period | 0 | |
| Cash and cash equivalents - end of period | $ 9 | 9 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||
| Interest paid | ||
| Income taxes paid |
Consolidated Balance Sheets (June 30, 2020 Unaudited) - USD ($) |
Jun. 30, 2020 |
Sep. 30, 2019 |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents | $ 9 | |
| TOTAL CURRENT ASSETS | 9 | |
| TOTAL ASSETS | 9 | |
| Current liabilities: | ||
| Due to related party | 45,627 | |
| TOTAL CURRENT LIABILITIES | 45,627 | |
| TOTAL LIABILITIES | 45,627 | |
| Stockholders' Deficit: | ||
| Preferred stock ($.0001 par value, 20,000,000 shares authorized; none issued and outstanding as of June 30, 2020 and September 30, 2019) | ||
| Common stock, $0.0001 par value; 500,000,000 shares authorized; 20,000,000 shares issued and outstanding as of June 30, 2020 and September 30, 2019 | 2,000 | 2,000 |
| Additional paid-in capital | (212) | (2,000) |
| Accumulated deficit | (47,354) | |
| Accumulated other comprehensive loss | (52) | |
| Total stockholders' deficit | (45,618) | |
| Total liabilities and stockholders' deficit | $ 9 |